Lentiviral-Mediated Transduction of Human Neurons for Tau Protein Aggregation Analysis

Overview

This article details a method for transducing mature human neurons with lentiviral vectors encoding a mutant tau protein fused to a yellow fluorescent protein (YFP). The process enables the study of tau protein aggregation in neuronal cells over time.

Key Study Components

Area of Science

• Neuroscience
• Cell Biology
• Gene Therapy

Background

• Mutant tau proteins are implicated in neurodegenerative diseases.
• Lentiviral vectors are effective tools for gene delivery in neurons.
• Understanding tau aggregation can provide insights into disease mechanisms.
• Fluorescent tagging allows for visualization of protein dynamics in live cells.

Purpose of Study

• To establish a reliable method for studying tau protein aggregation in human neurons.
• To visualize the effects of mutant tau on neuronal health and function.
• To contribute to the understanding of neurodegenerative disease pathology.

Methods Used

• Culture of mature human neurons in matrix-coated plates.
• Transduction with lentiviral vectors encoding mutant tau-YFP.
• Monitoring of protein aggregation using fluorescence microscopy.
• Regular media changes to maintain cell viability during the study.

Main Results

• Successful transduction of neurons with YFP-tagged mutant tau.
• Formation of cytoplasmic aggregates observed over time.
• Neuronal viability maintained throughout the eight-week culture period.
• Visual confirmation of protein aggregation via microscopy.

Conclusions

• The method effectively demonstrates tau protein aggregation in human neurons.
• Findings may enhance understanding of tau-related neurodegenerative processes.
• This approach can be utilized for further studies on tau and other proteins.

Frequently Asked Questions